1. Unusual Suspects in the Twilight Zone between the Hsp90 Interactome and Carcinogenesis<br>Evangelia Vartholomaiou, Pablo C. Echeverría and Didier Picard<br>2. Impact of Post-translational Modifications on the Anticancer Activity of Hsp90 Inhibitors<br>Mark R. Woodford, Diana Dunn, Jonelle B. Miller,Sami Jamal, Len Neckers and Mehdi Mollapour<br>3. Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects<br>Gaurav Garg, Anuj Khandelwal and Brian S. J. Blagg<br>4. HSP90 in Cancer: Transcriptional Roles in the Nucleus <br>S. K. Calderwood and L. Neckers<br>5. Hsp90 as a ‘Chaperone’ of the Epigenome: Insights and Opportunities for Cancer Therapy<br>Jennifer S. Isaacs<br>6. Emerging Roles of Extracellular Hsp90 in Cancer<br>Daniel Senh Wong and Daniel G. Jay<br>7. GRP94/gp96 in Cancer: Biology, Structure, Immunology and Drug Development <br>Bill X Wu, Feng Hong, Yongliang Zhang, Ephraim Ansa-Addo and Zihai Li<br>8. HSP90 and Immune Modulation in Cancer<br>Michael W. Graner<br>9. Hsp90: A Global Regulator of the Genotype-To-Phenotype Map in Cancers<br>Daniel Jarosz